文献

J-GLOBAL ID：201402255835706273   整理番号：14A0795025

急性冠症候群の日本人患者においてクロピドグレルと比較した調整用量のプラスグレルの有効性と安全性-PRASFIT-ACS研究-

Efficacy and Safety of Adjusted-Dose Prasugrel Compared With Clopidogrel in Japanese Patients With Acute Coronary Syndrome - The PRASFIT-ACS Study -

著者 (13件)： SAITO Shigeru (Div. of Cardiology, Shonan Kamakura General Hospital) ,  ISSHIKI Takaaki (Div. of Cardiology, Teikyo Univ. Hospital) ,  KIMURA Takeshi (Graduate School of Medicine, Kyoto Univ.) ,  OGAWA Hisao (Dep. of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto Univ.) ,  OGAWA Hisao (National Cerebral and Cardiovascular Center) ,  YOKOI Hiroyoshi (Cardiovascular Medicine Center, Fukuoka Sanno Hospital) ,  YOKOI Hiroyoshi (International Univ. of Health and Welfare) ,  NANTO Shinsuke (Dep. of Advanced Cardiovascular Therapeutics, Graduate School of Medicine, Osaka Univ.) ,  TAKAYAMA Morimasa (Sakakibara Heart Inst.) ,  KITAGAWA Kazuo (Dep. of Neurology, Graduate School of Medicine, Osaka Univ.) ,  NISHIKAWA Masakatsu (Inst. of Human Res. Promotion and Drug Dev., Fac. of Medicine, Mie Univ.) ,  MIYAZAKI Shunichi (Div. of Cardiology, Dep. of Medicine, Fac. of Medicine, Kinki Univ.) ,  NAKAMURA Masato (Div. of Cardiovascular Medicine, Ohashi Medical Center, Toho Univ.)
資料名： Circulation Journal  (Circulation Journal)
巻： 78  号： 7  ページ： 1684-1692 (J-STAGE)  発行年： 2014年 
JST資料番号： F0908A  ISSN： 1346-9843  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： プラスグレルはクロピドグレルより迅速,強力かつ一貫した血小板...

シソーラス用語： *冠動脈疾患 ,...
準シソーラス用語： *急性冠症候群 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=14A0795025&from=J-GLOBAL&jstjournalNo=F0908A") }}

分類 (2件)： 循環系疾患の薬物療法  (GJ05020M) ,  血液・体液作用薬の臨床への応用  (GW14020X)

物質索引 (3件)： アスピリン ,  クロピドグレル ,  プラスグレル

引用文献 (14件)：

•  1. JJCRAC/Data Center. Report of survey on treatment for cardiovascular disease 2008 in Japanese. http://www.j-circ.or.jp/jittai_chosa/jittai_chosa2008web.pdf (accessed July 16, 2010).
•  2. Anderson JL, Wright RS, Adams CD, Bridges CR, Casey DE Jr, Ettinger SM, et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2012; 60: 645–681.
•  3. Kushner FG, Hand M, Smith SC Jr, King SB 3rd, Anderson JL, Antman EM, et al. 2009 Focused updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009; 120: 2271–2306.
•  4. Park KW, Kim HS. Options to overcome clopidogrel response variability. Circ J 2012; 76: 287–292.
•  5. Wiviott SD, Trenk D, Frelinger AL, O’Donoghue M, Braunwald E, Michelson AD, et al. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: The Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial. Circulation 2007; 116: 2923–2932.

タイトルに関連する用語 (9件)： 急性冠症候群 ,  日本人 ,  患者 ,  クロピドグレル ,  用量 ,  プラスグレル ,  有効性 ,  安全性 ,  研究